Clinical trial
PPAR-COMBO With Sulfonylurea
NCT00162175
Study timeline
Study start (unknown)2003-07-01Date precision: month
Registry last updated2010-09-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metabolics Diabetes Nosunresolved
Interventions
MuraglitazarDRUG
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Mapped research locations
HoustonTexas, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1St LouisMissouri, United States1MiamiFlorida, United States1San AntonioTexas, United States1MadridSpain1CincinnatiOhio, United States1San DiegoCalifornia, United States1PortlandOregon, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00162175 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.